用語

 REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19  Weinreich DM, Sivapalasingam S, Norton T, et al.　〔N Engl J Med. 2021 Jan 21;384(3):238-251〕中和抗体カクテルREGN-COV2によるCOVID-19外来患者の治療　（日本語概要） Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7 Wang P, Nair MS, Liu L, et al.　〔Nature. 2021 Mar 8〕中和抗体に対するSARS-CoV-2変異株B.1.351およびB.1.1.7の耐性　（日本語概要） Casirivimab and imdevimab in patients admitted to hospital with COVID-19...

 SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19  Chen P, et al.〔N Engl J Med. 2021 Jan 21;384(3):229-237〕COVID-19外来患者でのSARS-CoV-2中和抗体LY-CoV555　（日本語概要） A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19 ACTIV-3/TICO LY-CoV555 Study Group　〔N Engl J Med. 2021; 384:905-914〕COVID-19入院患者を対象とした中和モノクローナル抗体による治療　（日本語概要）  Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With...

 Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia  Guimarães PO, Quirk D, Furtado RH, et al.〔N Engl J Med. 2021 Jul 29;385(5):406-415〕 COVID-19肺炎の入院患者におけるトファシチニブの投与　（日本語概要）

 Effectiveness of convalescent plasma therapy in severe COVID-19 patients.  Duan K, et al.　〔Proc Natl Acad Sci U S A. 2020 Apr 6.〕 COVID-19感染患者への回復期血漿療法の有効性　（日本語概要） Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. Shen C, et al.　〔JAMA. 2020 Mar 27〕回復期血漿輸血による重篤COVID-19患者5例への治療効果　（日本語概要） Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection. Zhang...

 Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study  Cavalli G, Larcher A, Tomelleri A, et al.　〔Lancet Respir Med. 2021 Mar 4:S2213-2600(21)00099-0〕過剰炎症反応を呈するCOVID-19患者におけるインターロイキン-1/インターロイキン-6阻害治療と標準治療の比較：コホート研究　（日本語概要）  IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study  Franzetti M, Forastieri...